Henry,
Looks like you're a celebrity, making the front page of The Street.com. But, Ouch! they gave you a little bit of rough treatment there. However, LGND did get some good publicity on the negotiations for the diabetes deal with LLY and others.
I took the liberty of rewriting the part about you as follows:
An intelligent Internet poster who graces several sites with his expertise in Ligand Pharmaceuticals (LGND:NASDAQ), Niman serves the online world as data analyst, biotech sage, and market guru. Henry tirelessly donates his time and energy to helping others, answering questions, providing links for further research, and teaching them to understand the intricacies of the biotech sector.
I've learned a tremendous amount reading your posts on the LGND thread, about biotechnology, cancer and diabetes research, even things like how to read intraday charts and analyze quotes and trade sizes. It's kind of like a stock market school for anyone with an interesting question about biotech. Here's the link if anyone wants to visit that site and judge for themselves:
exchange2000.com
GO LGND!!!!!!!!!!! |
